Literature DB >> 27940276

Maximal Inspiratory Pressure: Does the Choice of Reference Values Actually Matter?

Antenor Rodrigues1, Marianne L Da Silva2, Danilo C Berton3, Gerson Cipriano4, Fabio Pitta5, Denis E O'Donnell6, J Alberto Neder7.   

Abstract

BACKGROUND: Single-point measurements of maximal inspiratory pressure (MIP) are frequently used to suggest muscle weakness in clinical practice. Although there is a large variability in "mean" predicted MIP depending on the chosen reference values, it remains unclear whether those discrepancies actually impact on the prevalence of weakness, that is, MIP below the lower limit of normal.
METHODS: A total of 1,729 subjects (50.1% men, aged 20 to 94 years) who underwent MIP measurements in a clinical laboratory comprised the study group. MIP was predicted according to the most frequently cited regression equations as of August 2015. Pretest probability of weakness was defined by a cluster of clinical and physiologic variables.
RESULTS: Prevalence of weakness ranged from 33.4 to 66.9%. Set 2 equations agreed well in indicating weakness (κ [95% CI] ranging from 0.81 [0.79-0.83] to 0.83 [0.81-0.85]; P < .01). There was closer agreement between higher pretest probability of weakness and low MIP according to set 2 equations compared with set 1 equations. Thus, a significant fraction of subjects with abnormal MIP according to set 1 equations but preserved MIP according to set 2 equations had higher pretest probability of weakness (P < .05).
CONCLUSIONS: The choice of MIP reference values strongly impacts on the prevalence of weakness. Some specific equations relate better to clinical and physiologic indicators of weakness, suggesting that they might be particularly useful to screen subjects for advanced respiratory neuromuscular assessment.
Copyright © 2016 American College of Chest Physicians. Published by Elsevier Inc. All rights reserved.

Entities:  

Keywords:  dyspnea; lung function; pulmonary function test

Mesh:

Year:  2016        PMID: 27940276     DOI: 10.1016/j.chest.2016.11.045

Source DB:  PubMed          Journal:  Chest        ISSN: 0012-3692            Impact factor:   9.410


  12 in total

Review 1.  Inspiratory muscle weakness in cardiovascular diseases: Implications for cardiac rehabilitation.

Authors:  Joshua R Smith; Bryan J Taylor
Journal:  Prog Cardiovasc Dis       Date:  2021-10-22       Impact factor: 8.194

2.  Disease specific thresholds for determining extubation readiness: The optimal negative inspiratory force for chronic obstructive pulmonary disease patients.

Authors:  Amir Vahedian-Azimi; Farshid R Bashar; Marina N Boushra; Joseph W Quinn; Andrew C Miller
Journal:  Int J Crit Illn Inj Sci       Date:  2020-06-08

3.  Comparison between breath stacking technique associated with expiratory muscle training and breath stacking technique in amyotrophic lateral sclerosis patients: Protocol for randomized single blind trial.

Authors:  Alessandra Dorça; Livia A Alcântara; Denise Sisterolli Diniz; Max Sarmet; Sérgio Ricardo Menezes Mateus; Luis Vicente Franco Oliveira; Hamilton Franco; Vinicius Maldaner
Journal:  Contemp Clin Trials Commun       Date:  2020-09-02

Review 4.  Maximum inspiratory pressure as a clinically meaningful trial endpoint for neuromuscular diseases: a comprehensive review of the literature.

Authors:  Benedikt Schoser; Edward Fong; Tarekegn Geberhiwot; Derralynn Hughes; John T Kissel; Shyam C Madathil; David Orlikowski; Michael I Polkey; Mark Roberts; Harm A W M Tiddens; Peter Young
Journal:  Orphanet J Rare Dis       Date:  2017-03-16       Impact factor: 4.123

Review 5.  Advances in the Evaluation of Respiratory Pathophysiology during Exercise in Chronic Lung Diseases.

Authors:  Denis E O'Donnell; Amany F Elbehairy; Danilo C Berton; Nicolle J Domnik; J Alberto Neder
Journal:  Front Physiol       Date:  2017-02-22       Impact factor: 4.566

6.  Inspiratory muscle weakness contributes to exertional dyspnea in chronic thromboembolic pulmonary hypertension.

Authors:  João Victor Rolim; Jaquelina Sonoe Ota-Arakaki; Eloara V M Ferreira; Gabriela A M Figliolino; Ivan Ivanaga; Elaine Brito Vieira; Angelo X C Fonseca; Carolina M S Messina; Camila Melo Costa; J Alberto Neder; Luiz Eduardo Nery; Roberta Pulcheri Ramos
Journal:  PLoS One       Date:  2018-09-27       Impact factor: 3.240

Review 7.  Respiratory Muscle Performance Screening for Infectious Disease Management Following COVID-19: A Highly Pressurized Situation.

Authors:  Richard Severin; Ross Arena; Carl J Lavie; Samantha Bond; Shane A Phillips
Journal:  Am J Med       Date:  2020-04-25       Impact factor: 4.965

8.  Agreement between clinical and non-clinical digital manometer for assessing maximal respiratory pressures in healthy subjects.

Authors:  Rodrigo Torres-Castro; Nicolás Sepúlveda-Cáceres; Rodrigo Garrido-Baquedano; Marisol Barros-Poblete; Matías Otto-Yáñez; Luis Vasconcello; Roberto Vera-Uribe; Homero Puppo; Guilherme Fregonezi
Journal:  PLoS One       Date:  2019-10-24       Impact factor: 3.240

9.  Early Physical Therapist Interventions for Patients With COVID-19 in the Acute Care Hospital: A Case Report Series.

Authors:  Sabrina Eggmann; Angela Kindler; Andrea Perren; Natalie Ott; Frauke Johannes; Rahel Vollenweider; Théophile Balma; Claire Bennett; Ivo Neto Silva; Stephan M Jakob
Journal:  Phys Ther       Date:  2021-01-04

10.  RESPIRATORY MUSCLE IMPAIRMENT EVALUATED WITH MEP/MIP RATIO IN CHILDREN AND ADOLESCENTS WITH CHRONIC RESPIRATORY DISEASE.

Authors:  Iván Rodríguez-Núñez; Gerardo Torres; Soledad Luarte-Martinez; Carlos Manterola; Daniel Zenteno
Journal:  Rev Paul Pediatr       Date:  2020-12-18
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.